Second Chance for Moms Act
2/26/2025, 11:23 AMSummary of Bill HR 796
Bill 119 HR 796, also known as the "Mifepristone Labeling Act," aims to amend the Federal Food, Drug, and Cosmetic Act to require a warning label on mifepristone, a medication used for medical abortions, advising that its effects can be counteracted. The bill also seeks to amend the Public Health Service Act to establish a hotline that provides information to women seeking to counteract the effects of mifepristone.The purpose of this legislation is to ensure that women who have taken mifepristone are aware that there is a potential option to reverse its effects. By requiring a warning label on the medication packaging, women will be informed of the possibility of counteracting the medication if they change their minds after taking it.
Additionally, the establishment of a hotline will provide women with access to information and resources on how to reverse the effects of mifepristone. This hotline aims to support women who may be seeking to reverse the effects of the medication and make an informed decision about their reproductive health. Overall, the Bill 119 HR 796 aims to provide women with more information and options regarding the effects of mifepristone, ultimately empowering them to make the best decision for their health and well-being.
Current Status of Bill HR 796
Bill HR 796 is currently in the status of Bill Introduced since January 28, 2025. Bill HR 796 was introduced during Congress 119 and was introduced to the House on January 28, 2025. Bill HR 796's most recent activity was Referred to the House Committee on Energy and Commerce. as of January 28, 2025Bipartisan Support of Bill HR 796
Total Number of Sponsors
4Democrat Sponsors
0Republican Sponsors
4Unaffiliated Sponsors
0Total Number of Cosponsors
30Democrat Cosponsors
0Republican Cosponsors
30Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 796
Primary Policy Focus
Alternate Title(s) of Bill HR 796
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.Comments
Most relevant
Sponsors and Cosponsors of HR 796
Latest Bills
NORRA of 2025
Bill HR 1526March 26, 2025
Emerging Digital Identity Ecosystem Report Act of 2025
Bill HR 1925March 26, 2025
Veterans Patient Advocacy Act
Bill HR 2068March 26, 2025
Filing Relief for Natural Disasters Act
Bill HR 517March 26, 2025
Sanctuary City Accountability Act
Bill HR 1928March 26, 2025
Recognizing a century of broadcasting excellence from WOWO and celebrating the radio station's 100th anniversary.
Bill HRES 252March 26, 2025
Recognizing the significance of equal pay and the disparity between wages paid to men and women.
Bill HCONRES 21March 26, 2025
Providing for consideration of the bill (H.R. 1101) to prohibit unlawful access to the payment system of the Bureau of the Fiscal Service within the Department of the Treasury, and for other purposes.
Bill HRES 250March 26, 2025
Expressing support for the designation of the week of March 23, 2025, through March 29, 2025, as "National Cleaning Week".
Bill HRES 247March 26, 2025
Expressing support for the designation of May 15, 2025, as "Prader-Willi Syndrome Awareness Day" to raise awareness of and promote research on the disorder.
Bill HRES 253March 26, 2025